A peptide founder's first real merchant account

You launched your peptide brand on Stripe because it was the fastest checkout to stand up. Three weeks of orders, then the 6am email: account under review, funds held. Now you are reading every "high-risk merchant account" page on the internet at once, and half of them want your phone number before they will tell you a single number. This is the page that just tells you the numbers.

You are a first-time peptide founder. You have one brand, maybe a few thousand a month in volume, and you have never signed a merchant agreement that ran longer than a Stripe terms-of-service click-through. Here is what your first real merchant account actually looks like, and what the people selling them will not say out loud.

Why Stripe felt easy and then was not

Stripe, Square, PayPal, Shopify Payments, and Braintree all decline peptides under their acceptable use policies. That is not a rumor or a glitch. It is written policy. When you slipped through, you were not approved as a peptide brand. You were approved as whatever generic ecommerce category their instant signup assumed, and their review caught up with you later.

That is the whole story of the freeze. There is no appeal that fixes a policy violation. We wrote the longer version in why Stripe isn't built for peptide operators, but the short version is this: aggregators like Stripe pool thousands of merchants under one risk umbrella, and one peptide brand getting a chargeback spike threatens the pool. So the policy is to say no, and the enforcement is to close late rather than approve never.

The fix is not a cleverer Stripe application. The fix is a real merchant account at an acquirer that underwrites you, by name, as a peptide seller.

What a real merchant account costs a first-timer

Here is the part nobody puts on a landing page. Your first peptide merchant account will not be cheap, and the price is mostly about risk, not greed. A specialist ISO underwrites you individually, holds reserve against your future chargebacks, and prices the rate to survive your worst month.

The rolling reserve is the line that scares first-timers most. A 15% reserve held 180 days means that on every $100 you process, $15 sits with the acquirer for six months before it releases back to you. It is your money. It is delayed, not taken. We break down the mechanics in how peptide reserves are calculated.

The effective rate is the only number that matters

Sales reps love quoting a "rate" of 2.5% and then stacking gateway fees, monthly fees, batch fees, statement fees, and per-transaction add-ons on top. The number that matters is the effective rate: total fees divided by total volume, for one month, from a real statement.

For a first-year peptide operator, expect 3.5-4.5% effective. If a quote sounds dramatically cheaper, the difference is hiding in fees you have not been shown yet. Learn to read your own statement early, because the rate they quote and the rate you pay are rarely the same number.

Underwriting reads your website, not just your application

This is the surprise that closes more first-time founders than rate ever does. When you apply, a human at the acquirer opens your store and reads it. They check your product pages, your disclaimers, your refund policy, your about page, and your checkout.

• Product labeling: research-use framing without human-dosing instructions on the page.
• A visible, specific refund policy. "All sales final" with no exceptions reads as chargeback bait.
• An "FDA has not evaluated" statement where health claims appear.
• A COA reference per SKU, even if it is a request link rather than a hosted PDF.
• Contact information a real customer could use. A bare contact form reads as a flight risk.

What acquirers actually check is its own discipline, covered in peptide underwriting. Fix the website before you apply, not after the decline.

Who to apply to as a single-brand founder

This is where we are honest about our own limits. multiflow does not onboard single-brand peptide founders. We are the orchestration layer that sits on top of acquirers for operators running multiple brands. If you have one brand, we are the wrong call, and we will tell you that on the application.

For a first account, apply to two or three specialist ISOs in parallel and compare the actual contracts: EasyPayDirect, Durango, Soar, or Corepay. Soar is the most flexible on founders without six months of processing history. Apply to two, not ten. Every application is a credit and underwriting footprint, and a scattershot pattern reads as desperation. See our Durango comparison and Soar comparison for where each fits.

The first 90 days set your next two years

Whatever chargeback ratio you run in your first three months becomes the reserve and rate the acquirer offers you at renewal. Visa flags excessive at 0.9% and Mastercard at 1.0%, but your acquirer will get nervous well before that. Treat the first 90 days as the audition they are.

• Do not launch aggressive affiliate funnels before your processing is stable. Cold traffic charges back at higher rates.
• Answer support fast. Most chargebacks are customers who could not reach you.
• File representment on every dispute. Even the ones you lose teach the acquirer you fight.
• Keep your descriptor recognizable so customers know the charge is yours.

What to budget for the gap

There is a window between losing your Stripe checkout and going live on a specialist ISO. Underwriting takes 5-10 business days, sometimes longer if your site needs cleanup, so plan for it instead of panicking through it. Do not shut the brand down. Route high-value orders to alternative methods, ACH, Zelle, or wire, while the application runs, and tell repeat customers what is happening so a paused checkout does not become a wave of "where is my order" support tickets. Operators who plan the gap come out the other side with a cleaner first month of history, which is exactly the history that sets your year-two rate.

One more budgeting note: do not over-apply during the gap. Every specialist ISO application is an underwriting footprint, and a scattershot pattern of ten applications in a week reads as a distressed operator, which acquirers price accordingly. Two or three parallel applications is diligence; ten is a red flag.

When to come back to multiflow

You come back when you have three or more peptide brands and the pain stops being "getting approved" and starts being "managing five separate merchant accounts, five reserve schedules, and five statements." At that point a parent merchant account with brand-level descriptors and one consolidated ledger is worth the higher per-transaction cost. We sit on top of Stripe, Square, Authorize.net, or NMI as the orchestration layer; we never touch the payment ourselves. The structure is laid out on the peptide operator playbook, and the math on when it flips in your favor is in the true cost of multiple MIDs. Until then, the specialist-ISO path above is the right one, and there is no rush to consolidate before the brands exist.

If you are not sure whether you are a one-brand founder or a portfolio operator yet, that is exactly the conversation worth having. Run the 12-question application for an honest fit check. If a specialist ISO is the better first step, we will say so and point you there. No hard sell, no hard pull.